Squarepoint
CUE icon

Squarepoint’s Cue Biopharma CUE Stock Holding History

Squarepoint’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$435K Buy
+16,802
New +$498K ﹤0.01% 3486
2025
Q4 		– Sell
-2,860
Closed -$61.7K – 4369
2025
Q3 		$61.7K Buy
+2,860
New +$67.1K ﹤0.01% 4197
2025
Q2 		– Sell
-1,159
Closed -$31.7K – 4582
2025
Q1 		$31.7K Buy
1,159
+503
+77% +$18.7K ﹤0.01% 4404
2024
Q4 		$21.5K Buy
+656
New +$24.7K ﹤0.01% 4930
2024
Q3 		– Sell
-1,911
Closed -$71.1K – 4197
2024
Q2 		$71.1K Sell
1,911
-1,961
-51% -$97K ﹤0.01% 3861
2024
Q1 		$220K Buy
3,872
+2,418
+166% +$171K ﹤0.01% 3571
2023
Q4 		$115K Buy
1,454
+824
+131% +$58.9K ﹤0.01% 3730
2023
Q3 		$43.5K Buy
+630
New +$61.5K ﹤0.01% 3650
2023
Q2 		– Sell
-674
Closed -$72.2K – 3636
2023
Q1 		$72.2K Buy
+674
New +$64.3K ﹤0.01% 3021
2021
Q1 		– Sell
-874
Closed -$328K – 3198
2020
Q4 		$328K Buy
874
+209
+31% +$83.5K ﹤0.01% 2137
2020
Q3 		$300K Buy
+665
New +$383K ﹤0.01% 1800

Other funds holding CUE

UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Texas Capital Bank Wealth Management Services
Texas Capital Bank Wealth Management Services Dallas, Texas $1.94B AUM 19.18% 1-Year Est. Return
Robertson Stephens Wealth Management
Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Aster Capital Management
Aster Capital Management Dubai, United Arab Emirates $275M AUM 18.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

Squarepoint's CUE Position: Q3 2026 in Review

Squarepoint opened a new position in Cue Biopharma (CUE) in Q3 2026: 16,802 shares worth $435K. The stake represents ﹤0.01% of the portfolio and ranks #3486 among its holdings. This is a return to the name: Squarepoint previously reported a position in CUE as recently as Q3 2025.

Squarepoint first reported a position in CUE in Q3 2020 and has held it in 11 quarters since. 22 funds tracked by Wall St. Rank hold CUE as of Q3 2026.

  • Squarepoint held 16,802 shares of Cue Biopharma worth $435K as of Q3 2026.
  • Cue Biopharma was a new Squarepoint position in Q3 2026.
  • Cue Biopharma made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3486 holding.
  • Squarepoint first reported a position in Cue Biopharma in Q3 2020 and has held it in 11 quarters since.
  • 22 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.